This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Aug 31;116(15-16):508-10.

doi: 10.1007/BF03217702.

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon alpha--hype or hope?

PMID: 15471176
PMCID: PMC7088274
DOI: 10.1007/BF03217702

Editorial

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon alpha--hype or hope?

Wolfgang Vogel. Wien Klin Wochenschr. 2004.

. 2004 Aug 31;116(15-16):508-10.

doi: 10.1007/BF03217702.

Author

PMID: 15471176
PMCID: PMC7088274
DOI: 10.1007/BF03217702

No abstract available

PubMed Disclaimer

Comment on

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
Stauber RE, Hofer H, Hackl F, Schütze K, Datz C, Hegenbarth K, Jessner W, Steindl-Munda P, Peter F; Austrian Hepatitis Study Group. Stauber RE, et al. Wien Klin Wochenschr. 2004 Aug 31;116(15-16):530-5. doi: 10.1007/BF03217706. Wien Klin Wochenschr. 2004. PMID: 15471180 Clinical Trial.

Similar articles

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
Stauber RE, Hofer H, Hackl F, Schütze K, Datz C, Hegenbarth K, Jessner W, Steindl-Munda P, Peter F; Austrian Hepatitis Study Group. Stauber RE, et al. Wien Klin Wochenschr. 2004 Aug 31;116(15-16):530-5. doi: 10.1007/BF03217706. Wien Klin Wochenschr. 2004. PMID: 15471180 Clinical Trial.
Amantadine for treatment of hepatitis C: time to say "enough is enough"?
Piccolo P. Piccolo P. Dig Liver Dis. 2010 Jul;42(7):468-9. doi: 10.1016/j.dld.2010.04.009. Epub 2010 May 21. Dig Liver Dis. 2010. PMID: 20488769 No abstract available.
Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.
Younossi ZM, McCullough AC, Barnes DS, Post A, Ong JP, O'Shea R, Martin LM, Bringman D, Farmer D, Levinthal G, Mullen KD, Carey WD, Tavill AS, Ferguson R, Gramlich T. Younossi ZM, et al. Dig Dis Sci. 2005 May;50(5):970-5. doi: 10.1007/s10620-005-2673-y. Dig Dis Sci. 2005. PMID: 15906777 Clinical Trial.
[High dose repeat therapy in previously treated patients with chronic hepatitis C].
Hoepffner N, Paul KA, Nikodem AB, Teuber G. Hoepffner N, et al. Dtsch Med Wochenschr. 2006 Mar 17;131(11):543-4. doi: 10.1055/s-2006-933693. Dtsch Med Wochenschr. 2006. PMID: 16538557 Review. German. No abstract available.
[Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment].
Zoulim F. Zoulim F. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B225-30. Gastroenterol Clin Biol. 2002. PMID: 12180293 Review. French. No abstract available.

See all similar articles

References

1. Davis GL. Projecting future complications of chronic hepatitis C in the United States. Liv Transpl. 2003;9:331–338. doi: 10.1053/jlts.2003.50073. - DOI - PubMed
1. Davis GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology. 2002;36:s145–s151. doi: 10.1002/hep.1840360719. - DOI - PubMed
1. Smith JP. Treatment of chronic hepatitis C with amantadine. Dig Dis Sci. 1997;42:1681–1687. doi: 10.1023/A:1018857314351. - DOI - PubMed
1. Goff JS, Reveille RM, lohnson A. Treatment of chronic hepatitis C with amantadine. J Dig Dis Sci. 2000;45:1389–1391. doi: 10.1023/A:1005516322593. - DOI - PubMed
1. Di Martino V, Boudjema H, Delacour T, Cazier A, Caron C, Coutarel P, et al. Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/ or ribavirin. Clin Infect Dis. 2001;32:830–831. doi: 10.1086/319220. - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central